LXRX Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-03-13 | Artal International S.C.A. | director, 10 percent owner: | 1,150,922 | A-Award | A | 1,150,922 | 108.50 | 124,875,037.00 |
| 2024-02-28 | Alexander Kristen | officer: VP, Finance and Accounting | 59,593 | M-Exempt | A | 15,927 | 0.00 | 0.00 |
| 2024-02-28 | Alexander Kristen | officer: VP, Finance and Accounting | 47,800 | F-InKind | D | 11,793 | 2.62 | 30,898.00 |
| 2024-02-28 | Alexander Kristen | officer: VP, Finance and Accounting | 43,666 | M-Exempt | A | 10,616 | 0.00 | 0.00 |
| 2024-02-28 | Alexander Kristen | officer: VP, Finance and Accounting | 33,050 | M-Exempt | A | 2,700 | 0.00 | 0.00 |
| 2024-02-28 | Alexander Kristen | officer: VP, Finance and Accounting | 31,853 | M-Exempt | D | 15,927 | 0.00 | 0.00 |
| 2024-02-28 | Alexander Kristen | officer: VP, Finance and Accounting | 10,617 | M-Exempt | D | 10,616 | 0.00 | 0.00 |
| 2024-02-28 | Alexander Kristen | officer: VP, Finance and Accounting | 0 | M-Exempt | D | 2,700 | 0.00 | 0.00 |
| 2024-02-28 | WADE JEFFREY L | officer: President and CFO | 361,905 | M-Exempt | A | 49,113 | 0.00 | 0.00 |
| 2024-02-28 | WADE JEFFREY L | officer: President and CFO | 324,214 | F-InKind | D | 37,691 | 2.62 | 98,750.00 |
| 2024-02-28 | WADE JEFFREY L | officer: President and CFO | 312,792 | M-Exempt | A | 37,274 | 0.00 | 0.00 |
| 2024-02-28 | WADE JEFFREY L | officer: President and CFO | 275,518 | M-Exempt | A | 11,177 | 0.00 | 0.00 |
| 2024-02-28 | WADE JEFFREY L | officer: President and CFO | 98,227 | M-Exempt | D | 49,113 | 0.00 | 0.00 |
| 2024-02-28 | WADE JEFFREY L | officer: President and CFO | 37,273 | M-Exempt | D | 37,274 | 0.00 | 0.00 |
| 2024-02-28 | WADE JEFFREY L | officer: President and CFO | 0 | M-Exempt | D | 11,177 | 0.00 | 0.00 |
| 2024-02-28 | McDermott Wendy | officer: VP, Human Resources | 75,119 | M-Exempt | A | 27,697 | 0.00 | 0.00 |
| 2024-02-28 | McDermott Wendy | officer: VP, Human Resources | 55,393 | M-Exempt | D | 27,697 | 0.00 | 0.00 |
| 2024-02-28 | McDermott Wendy | officer: VP, Human Resources | 52,694 | F-InKind | D | 22,425 | 2.62 | 58,754.00 |
| 2024-02-28 | McDermott Wendy | officer: VP, Human Resources | 47,422 | M-Exempt | A | 18,944 | 0.00 | 0.00 |
| 2024-02-28 | McDermott Wendy | officer: VP, Human Resources | 18,943 | M-Exempt | D | 18,944 | 0.00 | 0.00 |
| 2024-02-28 | MAIN ALAN J | officer: EVP, Innov & Chem Sciences | 280,132 | M-Exempt | A | 32,903 | 0.00 | 0.00 |
| 2024-02-28 | MAIN ALAN J | officer: EVP, Innov & Chem Sciences | 255,724 | F-InKind | D | 24,408 | 2.62 | 63,949.00 |
| 2024-02-28 | MAIN ALAN J | officer: EVP, Innov & Chem Sciences | 247,229 | M-Exempt | A | 25,666 | 0.00 | 0.00 |
| 2024-02-28 | MAIN ALAN J | officer: EVP, Innov & Chem Sciences | 221,563 | M-Exempt | A | 8,977 | 0.00 | 0.00 |
| 2024-02-28 | MAIN ALAN J | officer: EVP, Innov & Chem Sciences | 65,807 | M-Exempt | D | 32,903 | 0.00 | 0.00 |
| 2024-02-28 | MAIN ALAN J | officer: EVP, Innov & Chem Sciences | 25,667 | M-Exempt | D | 25,666 | 0.00 | 0.00 |
| 2024-02-28 | MAIN ALAN J | officer: EVP, Innov & Chem Sciences | 0 | M-Exempt | D | 8,977 | 0.00 | 0.00 |
| 2024-02-28 | Kassler-Taub Kenneth B. | officer: SVP, Regulatory & QA | 187,025 | M-Exempt | A | 32,757 | 0.00 | 0.00 |
| 2024-02-28 | Kassler-Taub Kenneth B. | officer: SVP, Regulatory & QA | 162,672 | F-InKind | D | 24,353 | 2.62 | 63,805.00 |
| 2024-02-28 | Kassler-Taub Kenneth B. | officer: SVP, Regulatory & QA | 154,268 | M-Exempt | A | 27,556 | 0.00 | 0.00 |
| 2024-02-28 | Kassler-Taub Kenneth B. | officer: SVP, Regulatory & QA | 126,712 | M-Exempt | A | 7,087 | 0.00 | 0.00 |
| 2024-02-28 | Kassler-Taub Kenneth B. | officer: SVP, Regulatory & QA | 65,513 | M-Exempt | D | 32,757 | 0.00 | 0.00 |
| 2024-02-28 | Kassler-Taub Kenneth B. | officer: SVP, Regulatory & QA | 27,557 | M-Exempt | D | 27,556 | 0.00 | 0.00 |
| 2024-02-28 | Kassler-Taub Kenneth B. | officer: SVP, Regulatory & QA | 0 | M-Exempt | D | 7,087 | 0.00 | 0.00 |
| 2024-02-28 | Granowitz Craig B | officer: SVP, Chief Medical Officer | 78,891 | M-Exempt | A | 35,790 | 0.00 | 0.00 |
| 2024-02-28 | Granowitz Craig B | officer: SVP, Chief Medical Officer | 71,580 | M-Exempt | D | 35,790 | 0.00 | 0.00 |
| 2024-02-28 | Granowitz Craig B | officer: SVP, Chief Medical Officer | 47,626 | F-InKind | D | 31,265 | 2.62 | 81,914.00 |
| 2024-02-28 | Granowitz Craig B | officer: SVP, Chief Medical Officer | 43,101 | M-Exempt | A | 27,916 | 0.00 | 0.00 |
| 2024-02-28 | Granowitz Craig B | officer: SVP, Chief Medical Officer | 27,917 | M-Exempt | D | 27,916 | 0.00 | 0.00 |
| 2024-02-28 | Crum Brian T | officer: SVP, General Counsel & Secr. | 203,101 | M-Exempt | A | 33,457 | 0.00 | 0.00 |
| 2024-02-28 | Crum Brian T | officer: SVP, General Counsel & Secr. | 177,497 | F-InKind | D | 25,604 | 2.62 | 67,082.00 |
| 2024-02-28 | Crum Brian T | officer: SVP, General Counsel & Secr. | 169,644 | M-Exempt | A | 26,096 | 0.00 | 0.00 |
| 2024-02-28 | Crum Brian T | officer: SVP, General Counsel & Secr. | 143,548 | M-Exempt | A | 8,750 | 0.00 | 0.00 |
| 2024-02-28 | Crum Brian T | officer: SVP, General Counsel & Secr. | 66,913 | M-Exempt | D | 33,457 | 0.00 | 0.00 |
| 2024-02-28 | Crum Brian T | officer: SVP, General Counsel & Secr. | 26,097 | M-Exempt | D | 26,096 | 0.00 | 0.00 |
| 2024-02-28 | Crum Brian T | officer: SVP, General Counsel & Secr. | 0 | M-Exempt | D | 8,750 | 0.00 | 0.00 |
| 2024-02-28 | COATS LONNEL | director, officer: Chief Executive Officer | 1,159,439 | M-Exempt | A | 120,383 | 0.00 | 0.00 |
| 2024-02-28 | COATS LONNEL | director, officer: Chief Executive Officer | 1,098,068 | F-InKind | D | 61,371 | 2.62 | 160,792.00 |
| 2024-02-28 | COATS LONNEL | director, officer: Chief Executive Officer | 1,039,056 | M-Exempt | A | 91,364 | 0.00 | 0.00 |
| 2024-02-28 | COATS LONNEL | director, officer: Chief Executive Officer | 947,692 | M-Exempt | A | 33,333 | 0.00 | 0.00 |
| 2024-02-28 | COATS LONNEL | director, officer: Chief Executive Officer | 240,767 | M-Exempt | D | 120,383 | 0.00 | 0.00 |
| 2024-02-28 | COATS LONNEL | director, officer: Chief Executive Officer | 91,363 | M-Exempt | D | 91,364 | 0.00 | 0.00 |
| 2024-02-28 | COATS LONNEL | director, officer: Chief Executive Officer | 0 | M-Exempt | D | 33,333 | 0.00 | 0.00 |
| 2024-02-08 | Alexander Kristen | officer: VP, Finance and Accounting | 59,660 | A-Award | A | 59,660 | 0.00 | 0.00 |
| 2024-02-08 | Alexander Kristen | officer: VP, Finance and Accounting | 59,660 | A-Award | A | 59,660 | 2.15 | 128,269.00 |
| 2024-02-08 | WADE JEFFREY L | officer: President and CFO | 314,320 | A-Award | A | 314,320 | 0.00 | 0.00 |
| 2024-02-08 | WADE JEFFREY L | officer: President and CFO | 314,320 | A-Award | A | 314,320 | 2.15 | 675,788.00 |
| 2024-02-08 | McDermott Wendy | officer: VP, Human Resources | 156,950 | A-Award | A | 156,950 | 0.00 | 0.00 |
| 2024-02-08 | McDermott Wendy | officer: VP, Human Resources | 156,950 | A-Award | A | 156,950 | 2.15 | 337,442.00 |
| 2024-02-08 | MAIN ALAN J | officer: EVP, Innov & Chem Sciences | 204,730 | A-Award | A | 204,730 | 0.00 | 0.00 |
| 2024-02-08 | MAIN ALAN J | officer: EVP, Innov & Chem Sciences | 204,730 | A-Award | A | 204,730 | 2.15 | 440,170.00 |
| 2024-02-08 | Kassler-Taub Kenneth B. | officer: SVP, Regulatory & QA | 203,810 | A-Award | A | 203,810 | 0.00 | 0.00 |
| 2024-02-08 | Kassler-Taub Kenneth B. | officer: SVP, Regulatory & QA | 203,810 | A-Award | A | 203,810 | 2.15 | 438,192.00 |
| 2024-02-08 | Granowitz Craig B | officer: SVP, Chief Medical Officer | 222,680 | A-Award | A | 222,680 | 0.00 | 0.00 |
| 2024-02-08 | Granowitz Craig B | officer: SVP, Chief Medical Officer | 222,680 | A-Award | A | 222,680 | 2.15 | 478,762.00 |
| 2024-02-08 | Garner Thomas | officer: SVP, Chief Commercial Officer | 227,130 | A-Award | A | 227,130 | 0.00 | 0.00 |
| 2024-02-08 | Garner Thomas | officer: SVP, Chief Commercial Officer | 227,130 | A-Award | A | 227,130 | 2.15 | 488,330.00 |
| 2024-02-08 | Crum Brian T | officer: SVP, General Counsel & Secr. | 208,160 | A-Award | A | 208,160 | 0.00 | 0.00 |
| 2024-02-08 | Crum Brian T | officer: SVP, General Counsel & Secr. | 208,160 | A-Award | A | 208,160 | 2.15 | 447,544.00 |
| 2024-02-08 | COATS LONNEL | director, officer: Chief Executive Officer | 770,420 | A-Award | A | 770,420 | 0.00 | 0.00 |
| 2024-02-08 | COATS LONNEL | director, officer: Chief Executive Officer | 770,420 | A-Award | A | 770,420 | 2.15 | 1,656,403.00 |
| 2023-11-16 | COATS LONNEL | director, officer: Chief Executive Officer | 914,359 | P-Purchase | A | 90,000 | 1.05 | 94,797.00 |
| 2023-11-10 | COATS LONNEL | director, officer: Chief Executive Officer | 824,359 | P-Purchase | A | 10,000 | 1.01 | 10,100.00 |
| 2023-10-12 | DEBBANE RAYMOND | director | 1,340,847 | P-Purchase | A | 148,820 | 1.03 | 153,805.00 |
| 2023-10-11 | DEBBANE RAYMOND | director | 1,192,027 | P-Purchase | A | 342,874 | 1.08 | 370,784.00 |
| 2023-10-10 | DEBBANE RAYMOND | director | 849,153 | P-Purchase | A | 508,306 | 1.14 | 579,367.00 |
| 2023-10-09 | Garner Thomas | officer: SVP, Chief Commercial Officer | 248,923 | A-Award | A | 248,923 | 1.08 | 268,837.00 |
| 2023-10-09 | Garner Thomas | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2023-09-14 | WADE JEFFREY L | officer: President and CFO | 264,341 | P-Purchase | A | 10,000 | 1.38 | 13,800.00 |
| 2023-08-04 | McDermott Wendy | officer: VP, Human Resources | 28,478 | P-Purchase | A | 6,000 | 1.84 | 11,040.00 |
| 2023-07-27 | Sullivan Diane E. | director | 96,515 | A-Award | A | 96,515 | 1.94 | 187,239.00 |
| 2023-07-27 | Sullivan Diane E. | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2023-06-29 | COATS LONNEL | director, officer: Chief Executive Officer | 814,359 | P-Purchase | A | 10,000 | 2.16 | 21,600.00 |
| 2023-06-23 | McDermott Wendy | officer: VP, Human Resources | 22,478 | P-Purchase | A | 10,000 | 2.43 | 24,300.00 |
| 2023-06-26 | COATS LONNEL | director, officer: Chief Executive Officer | 804,359 | P-Purchase | A | 10,000 | 2.18 | 21,792.00 |
| 2023-06-23 | COATS LONNEL | director, officer: Chief Executive Officer | 794,359 | P-Purchase | A | 10,000 | 2.50 | 24,950.00 |
| 2023-06-22 | COATS LONNEL | director, officer: Chief Executive Officer | 784,359 | P-Purchase | A | 40,000 | 2.31 | 92,400.00 |
| 2023-06-20 | WADE JEFFREY L | officer: President and CFO | 254,341 | P-Purchase | A | 2,000 | 2.33 | 4,650.00 |
| 2023-06-20 | WADE JEFFREY L | officer: President and CFO | 252,341 | P-Purchase | A | 10,000 | 2.34 | 23,350.00 |
| 2023-06-05 | Artal International S.C.A. | director, 10 percent owner: | 78,634,381 | P-Purchase | A | 27,775,050 | 2.60 | 72,215,130.00 |
| 2023-05-21 | Swain Judith L | director | 40,332 | M-Exempt | A | 9,302 | 0.00 | 0.00 |
| 2023-05-21 | Swain Judith L | director | 0 | M-Exempt | D | 9,302 | 0.00 | 0.00 |
| 2023-05-21 | SOBECKI CHRISTOPHER J | director | 159,023 | M-Exempt | A | 9,302 | 0.00 | 0.00 |
| 2023-05-21 | SOBECKI CHRISTOPHER J | director | 0 | M-Exempt | D | 9,302 | 0.00 | 0.00 |
| 2023-05-21 | Palantoni Frank | director | 40,332 | M-Exempt | A | 9,302 | 0.00 | 0.00 |
| 2023-05-21 | Palantoni Frank | director | 0 | M-Exempt | D | 9,302 | 0.00 | 0.00 |
| 2023-05-21 | NIES ALAN S | director | 41,046 | M-Exempt | A | 9,302 | 0.00 | 0.00 |
| 2023-05-21 | NIES ALAN S | director | 0 | M-Exempt | D | 9,302 | 0.00 | 0.00 |
| 2023-05-21 | LEFKOWITZ ROBERT J MD | director | 40,332 | M-Exempt | A | 9,302 | 0.00 | 0.00 |
| 2023-05-21 | LEFKOWITZ ROBERT J MD | director | 0 | M-Exempt | D | 9,302 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
